Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 10-chloro-2,3,7,11b-tetrahydro-2-methyl-11b-phenylbenzo(6,7)(1,4)diazepino(5,4-b) Oxazol-6-one
2. Oxazolam, (trans)-isomer
3. Oxazolazepam
1. Oxazolazepam
2. Tranquit
3. Serenal
4. Hializan
5. 24143-17-7
6. Serenal [japanese]
7. 1v2wi2na1c
8. 10-chloro-2,3,7,11b-tetrahydro-2-methyl-11b-phenyloxazolo(3,2-d)(1,4)benzodiazepin-6(5h)-one
9. Benzo(6,7)-1,4-diazepino-(5,4-b)-oxazol-6-one, 10-chloro-2,3,5,6,7,11b-hexahydro-2-methyl-11b-phenyl-
10. Oxazolo[3,2-d][1,4]benzodiazepin-6(5h)-one, 10-chloro-2,3,7,11b-tetrahydro-2-methyl-11b-phenyl-
11. Oxazolamum
12. Convertal
13. 10-chloro-2,3,7,11b-tetrahydro-2-methyl-11b-phenyloxazolo[3,2-d][1,4]benzodiazepin-6(5h)-one
14. Oxazolo(3,2-d)(1,4)benzodiazepin-6(5h)-one, 10-chloro-2,3,7,11b-tetrahydro-2-methyl-11b-phenyl-
15. Oxazolam [inn:jan]
16. Oxazolamum [inn-latin]
17. Unii-1v2wi2na1c
18. 27167-30-2
19. Einecs 246-032-0
20. Serenal (tn)
21. Cs 300
22. Oxazolam [inn]
23. Oxazolam [jan]
24. Oxazolam [mi]
25. Oxazolam (jp17/inn)
26. Oxazolam [mart.]
27. Oxazolam [who-dd]
28. Estrone3-hemisuccinate
29. Dea No. 2839
30. Chembl2104805
31. Dtxsid5023401
32. Schembl10619798
33. Chebi:31944
34. Akos030242155
35. Db15491
36. (cis,trans)-10-chlor-2,3,5,6,7,11b-tetrahydro-2-methyl-11b-phenyloxazolo(3,2-d)(1,4)benzodiazepin-6(5h)-on
37. 10-chloro-2-methyl-11b-phenyl-2,3,5,7-tetrahydro-[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6-one
38. Oxazolo[3,2-d][1,4]benzodiazepin-6(5h)-one,10-chloro-2,3,7,11b-tetrahydro-2-methyl-11b-phenyl-
39. D01278
40. 167o302
41. 10-chloro-2,3,5,11b-tetrahydro-2-methyl-11b-phenyloxazolo[3,2-d][1,4]benzodiazepin-6(7h)-one
42. 10-chloro-2-methyl-11b-phenyl-2,3,7,11b-tetrahydro[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6(5h)-one #
| Molecular Weight | 328.8 g/mol |
|---|---|
| Molecular Formula | C18H17ClN2O2 |
| XLogP3 | 3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 1 |
| Exact Mass | 328.0978555 g/mol |
| Monoisotopic Mass | 328.0978555 g/mol |
| Topological Polar Surface Area | 41.6 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 468 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
ABOUT THIS PAGE
A Oxazolam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oxazolam, including repackagers and relabelers. The FDA regulates Oxazolam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oxazolam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Oxazolam supplier is an individual or a company that provides Oxazolam active pharmaceutical ingredient (API) or Oxazolam finished formulations upon request. The Oxazolam suppliers may include Oxazolam API manufacturers, exporters, distributors and traders.
click here to find a list of Oxazolam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Oxazolam Drug Master File in Japan (Oxazolam JDMF) empowers Oxazolam API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Oxazolam JDMF during the approval evaluation for pharmaceutical products. At the time of Oxazolam JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Oxazolam suppliers with JDMF on PharmaCompass.
Oxazolam Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Oxazolam GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Oxazolam GMP manufacturer or Oxazolam GMP API supplier for your needs.
A Oxazolam CoA (Certificate of Analysis) is a formal document that attests to Oxazolam's compliance with Oxazolam specifications and serves as a tool for batch-level quality control.
Oxazolam CoA mostly includes findings from lab analyses of a specific batch. For each Oxazolam CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Oxazolam may be tested according to a variety of international standards, such as European Pharmacopoeia (Oxazolam EP), Oxazolam JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oxazolam USP).
LOOKING FOR A SUPPLIER?
